Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

44 results about "Percent fat" patented technology

High protein corn product production and use

The present invention relates to the production of a highly digestible, high protein product (high protein distillers dried grains or high protein DDG) from corn endosperm, and more particularly to a method for the recovery of high protein DDG by using: (i) dehulling and degermination to isolate a low fat, low fiber corn endosperm fraction, (ii) enzymatic hydrolysis to solubilize and alcoholic fermentation to assimilate the starch and non-starch carbohydrates present in the corn endosperm, and (iii) filtration and/or centrifugation to recover the dealcoholized insoluble solids that remain after fermentation of the corn endosperm. The present invention provides an alternative to the traditional dry mill method of processing corn to produce ethanol, and results in the production and recovery of a distillers' by-product (high protein DDG) with increased value and range of use as an ingredient in feeds for farm-raised ruminants and non-ruminants and pet foods. The product of the present invention contains less than about 2.0 weight percent starch, from about 55.0 to about 65.0 weight percent protein, from about 4.5 to about 7.5 weight percent fat, from about 3.0 to about 5.0 weight percent crude fiber, and from about 78.0 to about 90.0 percent total digestible nutrients, and improves the palatability and digestibility of animal feeds and/or pet foods into which it is incorporated, and aids in the management of the health and weight gain of the animal.
Owner:GREENSTOCK RESOURCES

Compound evening primrose and perilla herb oil fat emulsion oral solution, beverage and preparation method

The invention provides a compound evening primrose and perilla herb oil fat emulsion oral solution, beverage and a preparation method. The oral solution comprises raw materials of evening primrose seed oil, perilla herb oil, lecithin, glycerin, sterile pure water, an antioxidant, a stabilizing agent, a pH regulating agent, a flavoring agent, essence, and the like. The preparation process comprises the following steps of: in the presence of the protection of nitrogen, heating, dissolving and mixing the evening primrose seed oil, the perilla herb oil and the lecithin into an oil phase; mixing the glycerin, the antioxidant, the stabilizing agent, the flavoring agent, the essence and the sterile pure water into a water phase; slowly adding the oil phase into the strongly stirred water phase and shearing into a primary emulsion at high speed; regulating the pH value of the primary emulsion to be 6.5-8.5 by using a few pH regulating agent; emulsifying by using a high-pressure homogenizer; filtering by using a microporous membrane; and filling, sealing and sterilizing to obtain the intravenous fluid the oil content of which is 1-50 percent. The compound evening primrose and perilla herb oil fat emulsion oral solution is used for the field of healthy food, a 5-50 percent fat emulsion oral solution can be used as nutritional functional health-care beverage, and a 1-20 percent fat emulsion oral solution can be used as table beverage and popular beverage.
Owner:王京南

Magnetic nanometer particulate of liposoluble photosensitizer and method for preparing the same

The present invention relates to a magnetic nanoparticle of a fat-soluble photosensitizer and a preparation method thereof; the present invention is the composite nanoparticle with the size of 5nm to 300nm which consists of 30 percent to 70 percent polysaccharide polymer, 5 percent to 40 percent fat-soluble photosensitizer and 10 percent to 50 percent iron-containing magnetic particles which have the magnetic response under the function of external magnetic field. The preparation method thereof is that the polysaccharide polymer is dissolved in alkaline solution, the emulsifier is added, the organic solvents which dissolves the fat-soluble photosensitizer are dropped during the agitating, so as to form the emulsion; the hydrate of ferrous salts and ferric salts is dropped into the emulsion during the agitating, so as to generate the black precipitate, then the magnetic nanoparticle of the fat-soluble photosensitizer can be obtained through the heating, pH valve regulation, getting the solid phase, washing, freezing and drying sequentially. The present invention has the advantages of safety, no toxicity, strong magnetic response and good biological acceptability, can entirely achieve the intravenous administration and significantly improve the targeting of the tumor under the magnetic guide function, so as to improve the photosensitive activity of the photosensitizer and achieve the purposes of reducing the dosage and lowering the toxic and side effects.
Owner:INST OF FIELD OPERATION SURGERY NO 3 MILITARY MEDICL UNIV PLA

Treating cachexia and excessive catabolism with (-)-hydroxycitric acid

InactiveUS20050009919A1Maintaining proper metabolic functioningMaintaining energy expenditureBiocideCarbohydrate active ingredientsEphedrineWeight decreasing
The inventor has discovered that (−)-hydroxycitric acid (including the forms of its various salts) is useful for treating and ameliorating cachexia, health-threatening catabolism and unhealthful weight loss, such as is characteristic of sarcopenia. The dosage will depend on factors such as the starting weight of the individual and the percentage of the calories in the diet derived from fats. On a 30 percent fat diet, an efficacious daily dosage for most individuals will be between 250 mg and 3 grams per day. It may prove beneficial to deliver the desired dosage only once per day, preferably prior to the noon meal. The weight-gain effects of HCA are compromised by the actions compounds such as caffeine and ephedrine, hence these should be avoided. Due to the biphasic characteristics of HCA, there is an obvious overlap between dosages that can lead to weight gain and the higher dosages that can lead to weight loss in those who are above their ideal body weights. There is little or no evidence that HCA ingested even in quite large amounts causes significant weight loss in individuals who are at or below their idea weights or exhibit a body mass index (BMI) at or below 20. It is to be expected that dosage will need to be matched to the current state of a given individual suffering from cachexia, catabolism or sarcopenia.
Owner:GLYKON TECH GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products